EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 / No 1 (Janvier 2009) Med Sci (Paris), 25 1 (2009) 64-68 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Number 1, Janvier 2009
Page(s) 64 - 68
Section M/S revues
DOI https://doi.org/10.1051/medsci/200925164
Published online 15 January 2009
  1. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346 : 2053–60. [Google Scholar]
  2. Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in feto-maternal allo-immunization and neonatal glomerulopathies. Lancet 2004; 364 : 1252–9. [Google Scholar]
  3. Hörl WH, Kerjaschki D. Membranous glomerulonephritis (MGN) J Nephrol 2000; 13 : 291–316. [Google Scholar]
  4. Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol 2005; 16 : 1214–22. [Google Scholar]
  5. Platt JL, Grant BW, Eddy AA, Michael AF. Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med 1983; 158 : 1227–42. [Google Scholar]
  6. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003; 21 : 3365–9. [Google Scholar]
  7. Clark MR. IgG effector mechanisms. Chem Immunol 1997; 65 : 88–110. [Google Scholar]
  8. Turner AJ, Brown CD, Carson JA, Barnes K. The neprilysin family in health and disease. Adv Exp Med Biol 2000; 477 : 229–40. [Google Scholar]
  9. Ikeda K, Emoto N, Raharjo SB, et al. Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J Biol Chem 1999; 274 : 32469–77. [Google Scholar]
  10. Bonvouloir N, Lemieux N, Crine P, et al. Molecular cloning, tissue distribution, and chromosomal localization of MMEL2, a gene coding for a novel human member of the neutral endopeptidase-24.11 family. DNA Cell Biol 2001; 20 : 493–8. [Google Scholar]
  11. Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 2005; 16 : 1205–13. [Google Scholar]
  12. Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008; 121 : e1615–21. [Google Scholar]
  13. Nortier JL, Debiec H, Tournay Y, et al. Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoring. Pediatr Nephrol 2006; 1 : 1399–405. [Google Scholar]
  14. Collinet P, Subtil D, Puech F, Vaast P. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization. Obstet Gynecol 2002; 100 : 1102–5. [Google Scholar]
  15. Ruggenenti P, Chiurchiu C, Brusegan V, et al. Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol 2003; 14 : 1851–7. [Google Scholar]
  16. Reynolds J, Prodromidi EI, Juggapah JK, et al. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 2005; 16 : 1350–9. [Google Scholar]
  17. Hall AM, Cairns LS, Altmann DM, et al. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 2005; 105 : 2175–9. [Google Scholar]
  18. Monteiro RC, Leroy V, Launay P, et al. Pathogénie de la maladie de Berger : Implication des immunoglobulines A et de leurs récepteurs. Med Sci (Paris) 2003; 19 : 1233–41. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.